Health

Adult B-ALL exhibits significant heterogeneity and poor prognosis compared with the pediatric population. While the complete remission (CR)…

On Jesse Vega’s first date with Deaunda Lira, a romantic sushi dinner in Colorado Springs three years ago,…

Peavoy has a diagnosis of schizophrenia and other mental health issues, the court has heard The Criminal Courts…

If you go hard at the gym, it’s important not to overlook recovery. Stretching, foam rolling, and hanging…

By CIARA FARMER Published: 10:52 EDT, 28 July 2026 | Updated: 11:16 EDT, 28 July 2026 She is…

A batch of adult mosquitoes collected in Oshawa have tested positive for West Nile virus, the second batch…

Your support helps us to tell the story From reproductive rights to climate change to Big Tech, The…

Imagine this scenario: It is 2023, and a woman we’ll call Jessica and her husband, Pedro, make the…

Alix Earle vulnerably opened up about her recent mental health struggles and suffering from a panic attack as…

Chloe Bailey had mercy on her comment section. After the 28-year-old shared a video of herself participating in…

The physical effects of air travel on the human body can range from mildly uncomfortable to life-threatening. With…

An FDA advisory panel recommended that six investigational peptides be eligible for compounding, but the agency has not…

Fixed-dose inotuzumab ozogamicin (INO) combined with Vincristine and Prednisone (VP) regimen as induction therapy for newly diagnosed B-cell acute lymphocytic leukemia (B-ALL): a multi-center, open-label, single-arm, prospective clinical study